2 completed, 2 terminated. 2 Phase 3, 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 4 | 1 | Terminated 1 |
Follow PRO-122: new trials by email Literature Review of PRO-122 trials Research Report on PRO-122
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparative Study of the Efficacy of Either Krytantek Ofteno PF® or Eliptic Ofteno PF® Plus Gaap Ofteno PF® for POAG or Ocular Hypertension. Dorzolamide-timolol-brimonidine and latanoprost, Dorzolamide-timolol and latanoprost - Glaucoma, Open-Angle, Ocular Hypertension | Phase 4 | Terminated | Laboratorios Sophia S.A de C.V. | 28 | 2021-10-19 | 2026-05-07 |
| Safety and Tolerability of the Preservative-free Ophthalmic Solution PRO-122 Compared With Krytantek Ofteno® PRO-122, Krytantek Ofteno® - Glaucoma | Phase 1 | Completed | Laboratorios Sophia S.A de C.V. | 24 | 2019-05-02 | 2019-12-13 |
| PRO-122 Versus Concomitant Therapy in Subjects With Uncontrolled Primary Open-angle Glaucoma (PRO-122LATAM) PRO-122, Timolol eye drops, Dorzolamide-Timolol Ophthalmic - Primary Open-angle Glaucoma | Phase 3 | Terminated | Laboratorios Sophia S.A de C.V. | 51 | 2017-11-06 | 2025-03-06 |
| Non-inferiority of PRO-122 Ophthalmic Solution vs KRYTANTEK Ofteno® in Glaucoma or Ocular Hypertension (CONFORTK) PRO-122, Krytantek Ofteno® - Primary Open Angle Glaucoma, Ocular Hypertension | Phase 3 | Completed | Laboratorios Sophia S.A de C.V. | 60 | 2016-04-01 | 2019-12-09 |
Glaucoma (3) · Glaucoma, Open-Angle (3) · Ocular Hypertension (2)
Laboratorios Sophia S.A de C.V. (4)
Mexico (3) · Colombia (1)